Home

átlátható hosztesz Monográfia antiphospholipidmilyen cső mély polc Tom Audreath

T sejtek és kemokinek változásának vizsgálata SLE pulmonalis  manifesztációjában Doktori értekezés Dr.Vincze Krisztina
T sejtek és kemokinek változásának vizsgálata SLE pulmonalis manifesztációjában Doktori értekezés Dr.Vincze Krisztina

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Nonstandard and adjunctive medical therapies for systemic lupus  erythematosus - McMurray - 2001 - Arthritis Care & Research - Wiley  Online Library
Nonstandard and adjunctive medical therapies for systemic lupus erythematosus - McMurray - 2001 - Arthritis Care & Research - Wiley Online Library

PDF) CLINICAL AND LABORATORY PROFILE OF BRAZILIAN PATIENTS WITH PRIMARY  ANTIPHOSPHOLIPID SYNDROME: COMPARISON WITH PATIENTS FROM OTHER PARTS OF THE  WORLD USING DATA FROM THE ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL  TRIALS AND
PDF) CLINICAL AND LABORATORY PROFILE OF BRAZILIAN PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: COMPARISON WITH PATIENTS FROM OTHER PARTS OF THE WORLD USING DATA FROM THE ANTIPHOSPHOLIPID SYNDROME ALLIANCE FOR CLINICAL TRIALS AND

The ANN for the 22-year-old male. | Download Scientific Diagram
The ANN for the 22-year-old male. | Download Scientific Diagram

Neutrophil Extracellular Traps May Augur Severe COVID-19 | The Scientist  Magazine®
Neutrophil Extracellular Traps May Augur Severe COVID-19 | The Scientist Magazine®

Treatment of lupus nephritis: consensus, evidence and perspectives | Nature  Reviews Rheumatology
Treatment of lupus nephritis: consensus, evidence and perspectives | Nature Reviews Rheumatology

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Biomedicines | November 2022 - Browse Articles
Biomedicines | November 2022 - Browse Articles

Marcus, Author at DiaPharma
Marcus, Author at DiaPharma

PDF) Immunogenicity and safety after SARS-CoV-2 vaccine in Primary  Antiphospholipid Syndrome (PAPS)
PDF) Immunogenicity and safety after SARS-CoV-2 vaccine in Primary Antiphospholipid Syndrome (PAPS)

COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity  Offers No Protection Against SARS-CoV-2 - Thailand Medical News
COVID-19 Breaking News! French Study Confirms Previous Coronavirus Immunity Offers No Protection Against SARS-CoV-2 - Thailand Medical News

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Logistic regression predicting those with >80% time in therapeutic range |  Download Table
Logistic regression predicting those with >80% time in therapeutic range | Download Table

Inhibition of the mtorc pathway in the antiphospholipid
Inhibition of the mtorc pathway in the antiphospholipid

Savino Sciascia (@SavinoSciascia) / Twitter
Savino Sciascia (@SavinoSciascia) / Twitter

Savino Sciascia (@SavinoSciascia) / Twitter
Savino Sciascia (@SavinoSciascia) / Twitter

Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of  Glycosaminoglycans and Activated Protein C
Frontiers | Thrombosis and Inflammation—A Dynamic Interplay and the Role of Glycosaminoglycans and Activated Protein C

Diagnosis and treatment of lupus nephritis. Consensus document from the  systemic auto-immune disease group (GEAS) of the Spanish Society of  Internal Medicine (SEMI) and the Spanish Society of Nephrology (S.E.N.) |  Nefrología
Diagnosis and treatment of lupus nephritis. Consensus document from the systemic auto-immune disease group (GEAS) of the Spanish Society of Internal Medicine (SEMI) and the Spanish Society of Nephrology (S.E.N.) | Nefrología

Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic  Lupus Erythematosus Treatment Towards Personalized Medicine
Frontiers | Genetic Polymorphisms and the Clinical Response to Systemic Lupus Erythematosus Treatment Towards Personalized Medicine

Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three  Common Neurodegenerative Diseases | ALS Therapy Development Institute
Blog: ALS vs MS vs Parkinson's Disease: The Differences Between Three Common Neurodegenerative Diseases | ALS Therapy Development Institute

PDF) Non-criteria Antiphospholipid Antibodies: a narrative review
PDF) Non-criteria Antiphospholipid Antibodies: a narrative review

Savino Sciascia (@SavinoSciascia) / Twitter
Savino Sciascia (@SavinoSciascia) / Twitter

Update on the Treatment of Systemic Lupus Erythematosus - Ana M Arango,  John D Reveille, 2006
Update on the Treatment of Systemic Lupus Erythematosus - Ana M Arango, John D Reveille, 2006

JCM | Free Full-Text | Old and New Calcineurin Inhibitors in Lupus Nephritis
JCM | Free Full-Text | Old and New Calcineurin Inhibitors in Lupus Nephritis

PDF) Clinical and laboratory characteristics of Brazilian versus  non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid  Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS  ACTION) clinical database and repository
PDF) Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository